Bill Blackledge

Bill Blackledge is the Chief Financial Officer at Cytovale, a company specializing in rapid sepsis diagnosis. Prior to this role, Bill served as the Vice President at Pfenex Inc and BD, where Bill focused on business operations and commercial growth. With a strong background in finance and accounting, Bill has held various leadership positions in the medical technology industry, managing customer facing finance, sales support, and investor relations. Bill has a BS in Business Economics & Accounting from UCLA and has extensive experience in financial management and business development.